AstraZeneca PLC (AZN) — Capital Reinvestment Ratio
AstraZeneca PLC (AZN) has a Capital Reinvestment Ratio of 0.26x as of June 2026, meaning it reinvests 0% of its operating cash flow (GBX2.91 Billion) in capital expenditures (GBX757.64 Million). Check tangible net worth ratio of AstraZeneca PLC to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AstraZeneca PLC Capital Reinvestment Ratio (1990–2025)
This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 36 annual periods. For the full cash flow conversion analysis, see AstraZeneca PLC operating cash flow efficiency.
Annual Capital Reinvestment Ratio for AstraZeneca PLC (1990–2025)
Year-by-year Capital Reinvestment Ratio for AstraZeneca PLC from 1990 to 2025. See AZN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.41x | GBX14.57 Billion | GBX5.91 Billion | ▲ +4.8% |
| 2024 | 0.39x | GBX11.86 Billion | GBX4.59 Billion | ▲ +5.9% |
| 2023 | 0.37x | GBX10.35 Billion | GBX3.78 Billion | ▲ +39.3% |
| 2022 | 0.26x | GBX9.81 Billion | GBX2.57 Billion | ▼ -29.0% |
| 2021 | 0.37x | GBX5.96 Billion | GBX2.20 Billion | ▼ -32.1% |
| 2020 | 0.54x | GBX4.80 Billion | GBX2.61 Billion | ▼ -34.5% |
| 2019 | 0.83x | GBX2.97 Billion | GBX2.46 Billion | ▲ +58.2% |
| 2018 | 0.52x | GBX2.62 Billion | GBX1.37 Billion | ▲ +15.7% |
| 2017 | 0.45x | GBX3.58 Billion | GBX1.62 Billion | ▼ -18.9% |
| 2016 | 0.56x | GBX4.14 Billion | GBX2.31 Billion | ▼ -33.4% |
| 2015 | 0.84x | GBX3.32 Billion | GBX2.79 Billion | ▲ +115.1% |
| 2014 | 0.39x | GBX7.06 Billion | GBX2.75 Billion | ▲ +40.2% |
| 2013 | 0.28x | GBX7.40 Billion | GBX2.06 Billion | ▼ -58.2% |
| 2012 | 0.66x | GBX6.95 Billion | GBX4.62 Billion | ▲ +300.9% |
| 2011 | 0.17x | GBX7.82 Billion | GBX1.30 Billion | ▼ -26.8% |
| 2010 | 0.23x | GBX10.68 Billion | GBX2.42 Billion | ▼ -10.0% |
| 2009 | 0.25x | GBX11.74 Billion | GBX2.96 Billion | ▼ -45.5% |
| 2008 | 0.46x | GBX8.74 Billion | GBX4.04 Billion | ▲ +106.7% |
| 2007 | 0.22x | GBX7.51 Billion | GBX1.68 Billion | ▲ +28.4% |
| 2006 | 0.17x | GBX7.69 Billion | GBX1.34 Billion | ▲ +19.9% |
| 2005 | 0.15x | GBX6.74 Billion | GBX979.00 Million | ▲ +113.1% |
| 2004 | 0.07x | GBX4.87 Billion | GBX332.00 Million | ▼ -81.8% |
| 2003 | 0.38x | GBX3.42 Billion | GBX1.28 Billion | ▲ +35.4% |
| 2002 | 0.28x | GBX4.83 Billion | GBX1.34 Billion | ▼ -66.8% |
| 2001 | 0.84x | GBX2.71 Billion | GBX2.26 Billion | ▲ +33.7% |
| 2000 | 0.63x | GBX2.34 Billion | GBX1.46 Billion | ▼ -79.4% |
| 1999 | 3.03x | GBX908.55 Million | GBX2.75 Billion | ▲ +215.4% |
| 1998 | 0.96x | GBX879.74 Million | GBX844.88 Million | ▼ -5.0% |
| 1997 | 1.01x | GBX747.21 Million | GBX755.47 Million | ▲ +24.7% |
| 1996 | 0.81x | GBX787.75 Million | GBX638.76 Million | ▲ +10.2% |
| 1995 | 0.74x | GBX585.64 Million | GBX431.11 Million | ▼ -6.5% |
| 1994 | 0.79x | GBX625.36 Million | GBX492.47 Million | ▲ +20.0% |
| 1993 | 0.66x | GBX705.58 Million | GBX462.99 Million | ▼ -66.7% |
| 1992 | 1.97x | GBX206.27 Million | GBX406.47 Million | ▲ +158.3% |
| 1991 | 0.76x | GBX505.22 Million | GBX385.46 Million | ▲ +13.9% |
| 1990 | 0.67x | GBX806.30 Million | GBX540.10 Million | — |